1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

08 May 2024
Admin
News Article

Naprod Life Sciences Renews EU-GMP Certification for its Palghar Facility

Overview

Naprod Life Sciences has announced the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar. The approval marks a significant milestone for Naprod in its journey of global leadership. The audit was conducted in December 2023 by The National Institute of Pharmacy and Nutrition (OGYÉI), Hungary.

Words from Naprod Life Sciences

Speaking on the development, Mohan Jain, managing director at Naprod Life Sciences said, “The EU GMP certification for our facility in Palghar is a testament to our consistent efforts to comply with the highest quality standards. We are committed to being compliant and supplying quality products to our customers and patients across the globe.”

EU-GMP Certification

The EU-GMP certification highlights the Palghar facility’s capabilities to ensure consistent and controlled production in accordance with the EU’s quality standards.
The facility produces a wide range of formulations, liquid and lyophilised injectable products, with a special focus on oncology, anaesthetics and other therapy segments.

Naprod Life Sciences Pvt. Ltd.

Naprod Life Sciences Pvt. Ltd. (Naprod) is a leading Indian pharmaceutical company established in 1994, headquartered in Mumbai.
Naprod has grown to become a global leader in oncology and anaesthesia medications for both the Indian and international markets through excellence in innovation, the discovery of new manufacturing processes, drug delivery mechanisms and a consistent commitment to quality.

Company’s Portfolio

With over 550 employees, Naprod primarily manufactures and sells formulations and specialty injectables.
The company’s portfolio includes products for oncology, cardiovascular, anaesthetic, anti-ulcerative and anti-Infective medicines.
The company has one manufacturing plant in Palghar, Maharashtra. The plant holds accreditations by multiple regulatory authorities including EU GMP, ANVISA Brazil, INVIMA Colombia, PICS, and authorities in Africa and CIS countries.